Human medicine and SMOPshttps://www.ema.europa.eu/en/homepageHuman medicines: European public assessment reports (EPARs)en-gbCopyright: (C) European Medicines AgencyWed, 17 Apr 2024 18:29:15 +0200Fri, 22 Mar 2024 12:00:44 +0100Summary of opinion: Xtandi, 21/03/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/xtandiSummary of opinion: Xtandi, 21/03/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/xtandiFri, 22 Mar 2024 12:00:44 +0100Human medicine and SMOPsSummary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/onivyde-pegylated-liposomal-previously-known-onivydeSummary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/onivyde-pegylated-liposomal-previously-known-onivydeFri, 22 Mar 2024 12:00:00 +0100Human medicine and SMOPs